Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau by Niklas Mattsson‐Carlgren, Shorena Janelidze, Randall J Bateman, Ruben Smith, Erik Stomrud, Geidy E Serrano, Eric M Reiman, Sebastian Palmqvist, Jeffrey L Dage, Thomas G Beach, Oskar Hansson

Subjects: Get full text

Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein by Xifeng Wang, Huayu Yang, Dengcheng Zhan, Haiying Sun, Qiang Huang, Yiping Zhang, Yue Lin, Gen Wei, Fuzhou Hua, Li Liu, Shibiao Chen

Subjects: Get full text

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort by Divya Bali, Gemma Salvadó, Thomas G. Beach, Geidy E. Serrano, Alireza Atri, Eric M. Reiman, Andreas Jeromin, Oskar Hansson, Shorena Janelidze

Subjects: Get full text

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women by Alexandra Paget‐Blanc, Rebecca C. Thurston, Stephen F. Smagula, Yuefang Chang, Pauline M. Maki

Subjects: Get full text

Astaxanthin attenuates DNA fragmentation and cognitive decline in type 2 diabetic rats by Sohair A. Saleh, Gergess S. Hanna, Sobhy H. El-Naby, Suzy F. Ewida, Rasha S. A. Elseadawy, Basma S. Ghoneim, Shaimaa M. Motawea

Subjects: Get full text

Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals by Henry Gilreath Stephenson, Tobey J. Betthauser, Rebecca Langhough, Erin Jonaitis, Lianlian Du, Carol Van Hulle, Gwendlyn Kollmorgen, Clara Quijano‐Rubio, Nathaniel A. Chin, Ozioma C. Okonkwo, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin

Subjects: Get full text

Rock inhibitors in Alzheimer’s disease by Chao Zheng, Chao Zheng, Weiming Xia, Weiming Xia, Weiming Xia, Jianhua Zhang

Subjects: Get full text

Electrochemical modulation of tau protein phosphorylation levels with biomimetic polyaniline membranes by Shang-Chi Chien, Chia-Hsuan Chang, Hung-Ju Wang, Chien-Chih Hsu, Yu-Lin Wang, Ching-Cheng Chuang, Jung-Chih Chen

Subjects: “…Phosphorylated tau…”
Get full text

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data by Masahiro Hata, Yuki Miyazaki, Kohji Mori, Kenji Yoshiyama, Shoshin Akamine, Hideki Kanemoto, Shiho Gotoh, Hisaki Omori, Atsuya Hirashima, Yuto Satake, Takashi Suehiro, Shun Takahashi, Manabu Ikeda

Subjects: Get full text

Functional Analysis of Direct In Vitro Effect of Phosphorylated Tau on Mitochondrial Respiration and Hydrogen Peroxide Production by Zdeněk Fišar, Jana Hroudová

Subjects: Get full text

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217 by Branislav Kovacech, Nicholas C. Cullen, Petr Novak, Jozef Hanes, Eva Kontsekova, Stanislav Katina, Vojtech Parrak, Michal Fresser, Jeroen Vanbrabant, Howard H. Feldman, Bengt Winblad, Erik Stoops, Eugeen Vanmechelen, Norbert Zilka

Subjects: Get full text

Phosphorylated TDP-43 and tau deposition around the tip of deep brain stimulation leads by Goichi Beck, Yuki Yonenobu, Kenichiro Maeda, Satoru Oshino, Haruhiko Kishima, Masanori P. Takahashi, Hideki Mochizuki, Shigeo Murayama

Subjects: Get full text

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis... by Annibale Antonioni, Emanuela Maria Raho, Lamberto Manzoli, Giacomo Koch, Maria Elena Flacco, Francesco Di Lorenzo

Subjects: Get full text

Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy by Takanobu Ishiguro, Kensaku Kasuga

Subjects: Get full text

The two cut‐offs approach for plasma p‐tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment by Giulia Giacomucci, Chiara Crucitti, Assunta Ingannato, Valentina Moschini, Silvia Bagnoli, Federico Emanuele Pozzi, Elisa Marcantelli, Sonia Padiglioni, Carmen Morinelli, Salvatore Mazzeo, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi

Subjects: Get full text

Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer’s disease and other neurodegenerative dementias in a large Chinese cohort by Bin Jiao, Ziyu Ouyang, Yiliang Liu, Cong Zhang, Tianyan Xu, Qijie Yang, Sizhe Zhang, Yuan Zhu, Meidan Wan, Xuewen Xiao, Xixi Liu, Yafang Zhou, Xinxin Liao, Weiwei Zhang, Shilin Luo, Beisha Tang, Lu Shen

Subjects: Get full text

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics by Marco Agostini, Pietro Traldi, Mahmoud Hamdan

Subjects: Get full text

Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort by Frederikke Kragh Clemmensen, Mathias Holsey Gramkow, Anja Hviid Simonsen, Nicholas J. Ashton, Hanna Huber, Kaj Blennow, Henrik Zetterberg, Gunhild Waldemar, Steen Gregers Hasselbalch, Kristian Steen Frederiksen

Subjects: “…Intra- and Inter-individual variability, Reference change value (RCV), Plasma Aβ42/Aβ40 ratio, Phosphorylated tau (p-tau), Neurofilament light (NfL), Glial fibrillary acidic protein (GFAP)…”
Get full text